Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2007-07-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BBRC.2007.05.093PMID 17543886
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

  2006cited by this paper
• Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles.

  2006cited by this paper
• Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease

  2005cited by this paper
• Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

  2005cited by this paper
• Therapeutics development for triplet repeat expansion diseases

  2005cited by this paper
• Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease

  2005cited by this paper
• Akt is altered in an animal model of Huntington's disease and in patients

  2005cited by this paper
• Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress.

  2005cited by this paper
• Tryptophan metabolism and oxidative stress in patients with Huntington's disease

  2005cited by this paper
• Autophagosome-like vacuole formation in Huntington's disease lymphoblasts

  2004cited by this paper
• Humic Acid Induces Oxidative DNA Damage, Growth Retardation, and Apoptosis in Human Primary Fibroblasts

  2003cited by this paper
• Rapid mtDNA deletion by oxidants in rat liver mitochondria after hemin exposure.

  2002cited by this paper
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

  2002cited by this paper
• Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples.

  2002cited by this paper
• Comparative Analysis of Superoxide Dismutase Activity between Acute Pharmacological Models and a Transgenic Mouse Model of Huntington's Disease

  2001cited by this paper
• Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells.

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease.

  2000cited by this paper
• Ca2+‐Dependent Permeability Transition and Complex I Activity in Lymphoblast Mitochondria from Normal Individuals and Patients with Huntington's or Alzheimer's Disease

  1999cited by this paper
• Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization

  1999cited by this paper
• Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex.

  1999cited by this paper
• Biochemical abnormalities and excitotoxicity in Huntington's disease brain

  1999cited by this paper
• Ca(2+)-dependent permeability transition and complex I activity in lymphoblast mitochondria from normal individuals and patients with Huntington's or Alzheimer's disease.

  1999cited by this paper
• Oxidative Stress in Huntington's Disease

  1999cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

  1997cited by this paper
• Mitochondrial defect in Huntington's disease caudate nucleus

  1996cited by this paper
• Unified Huntington's disease rating scale: Reliability and consistency

  1996cited by this paper
• Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients

  1995cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Normal oxidative damage to mitochondrial and nuclear DNA is extensive.

  1988cited by this paper
• Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain

  1985cited by this paper
• Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

  1967cited by this paper

• Animal Models for the Study of Neurological Diseases and Their Link to Sleep

  2025cites this paper
• Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia

  2025cites this paper
• The Antioxidant Role of Aromatic Plant Extracts in Managing Neurodegenerative Diseases: A Comprehensive Review.

  2025cites this paper
• Fluid-based biomarkers for neurodegenerative diseases.

  2025cites this paper
• Mitochondrial Dynamics in Neurodegenerative Diseases: Research Hotspots and Trends from 2005 to 2025.

  2025cites this paper
• Protective Effects of Sulforaphane Preventing Inflammation and Oxidative Stress to Enhance Metabolic Health: A Narrative Review

  2025cites this paper
• Diagnostic role of circulating cell-free DNA in schizophrenia and neuro-degenerative disorders.

  2025cites this paper
• Short-chain fatty acids in Huntington's disease: Mechanisms of action and their therapeutic implications.

  2025cites this paper
• Oxidative Stress in Huntington’s Disease

  2025influential citation
• CHCHD2 up-regulation in Huntington disease mediates a compensatory protective response against oxidative stress

  2024cites this paper
• The Role of NRF2 in Trinucleotide Repeat Expansion Disorders

  2024cites this paper
• Beyond CAG Repeats: The Multifaceted Role of Genetics in Huntington Disease

  2024cites this paper
• Role of Mitochondrial Dysfunctions in Neurodegenerative Disorders: Advances in Mitochondrial Biology

  2024cites this paper
• Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

  2024cites this paper
• Rosmarinic acid ameliorated oxidative stress, neuronal injuries, and mitochondrial dysfunctions mediated by polyglutamine and ɑ-synuclein in Caenorhabditis elegans models

  2024cites this paper
• The Role of Mitochondrial Copy Number in Neurodegenerative Diseases: Present Insights and Future Directions

  2024cites this paper
• Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease

  2024cites this paper
• Mechanisms of Ferritinophagy and Ferroptosis in Diseases

  2023cites this paper
• Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases

  2023cites this paper
• Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson

  2023cites this paper
• Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy

  2023cites this paper
• Targeted to neuronal organelles for CNS drug development.

  2023cites this paper
• The updated development of blood-based biomarkers for Huntington’s disease

  2023cites this paper
• Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness

  2023cites this paper
• Ferroptosis: underlying mechanisms and involvement in neurodegenerative diseases

  2023cites this paper
• Basic Leucine Zipper Protein Nuclear factor erythroid 2-related factor 2 as a Potential Therapeutic Target in Brain Related Disorders.

  2022cites this paper
• HSF1 and Its Role in Huntington's Disease Pathology.

  2022cites this paper
• Role and mechanism of ferroptosis in neurological diseases

  2022cites this paper
• Acanthocytes Identified in Huntington’s Disease

  2022cites this paper
• Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?

  2022cites this paper
• Mitochondrial and redox modifications in early stages of Huntington's disease

  2022cites this paper
• Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?

  2021cites this paper
• Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease

  2021cites this paper
• Cerebral venous thrombosis, neutropenia and iron-deficiency anemia in Huntington disease.

  2021cites this paper
• Free radical biology in neurological manifestations: mechanisms to therapeutics interventions

  2021cites this paper
• What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease

  2021cites this paper
• Investigating Crosstalk Among PTMs Provides Novel Insight Into the Structural Basis Underlying the Differential Effects of Nt17 PTMs on Mutant Httex1 Aggregation

  2021cites this paper
• Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions

  2021cites this paper
• Can a Micronutrient Mixture Delay the Onset and Progression of Symptoms of Single-Point Mutation Diseases?

  2021cites this paper
• Neuroinflammation in Huntington’s

  2021cites this paper
• An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases

  2021cites this paper
• Metabolism in Huntington’s disease: a major contributor to pathology

  2021cites this paper
• Uncoupling proteins in the mitochondrial defense against oxidative stress.

  2021cites this paper
• Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes.

  2021cites this paper
• Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum

  2021cites this paper
• Plasma Phospholipids: A Promising Simple Biochemical Parameter to Evaluate COVID-19 Infection Severity

  2021cites this paper
• New Avenues for the Treatment of Huntington’s Disease

  2021cites this paper
• NRF2 as a Therapeutic Target in Neurodegenerative Diseases

  2020influential citation
• The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons

  2020cites this paper
• Role of cellular oxidative stress in dementia

  2020cites this paper
• Evaluation of an Antioxidant and Anti-inflammatory Cocktail Against Human Hypoactivity-Induced Skeletal Muscle Deconditioning

  2020cites this paper
• Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients

  2020cites this paper
• Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

  2020cites this paper
• Inflammation in Huntington's disease: A few new twists on an old tale.

  2020cites this paper
• Ferroptosis and kidney disease.

  2020cites this paper
• Uric Acid as a Potential Peripheral Biomarker for Disease Features in Huntington’s Patients

  2020cites this paper
• Blood Oxidative Stress Marker Aberrations in Patients with Huntington's Disease: A Meta-Analysis Study

  2020cites this paper
• Determining the Fate of Neurons in SCA3: ATX3, a Rising Decision Maker in Response to DNA Stresses and Beyond

  2020cites this paper
• Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement

  2020cites this paper
• The interaction of aging and oxidative stress contributes to pathogenesis in mouse and human Huntington disease neurons

  2019influential citation
• Long chain lipid hydroperoxides increase the glutathione redox potential through glutathione peroxidase 4.

  2019cites this paper
• Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein

  2019cites this paper
• Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications

  2019cites this paper
• ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects

  2019cites this paper
• A Cell-Based Approach to Study the Associations Between Mitochondrial Health, Early Life Exposures, and Consequent Health Outcomes

  2019cites this paper
• Ferroptosis in Nervous System Diseases

  2019cites this paper
• Phospholipid oxidation products in Ferroptotic Myocardial Cell Death.

  2019cites this paper
• Expression of Human Mutant Huntingtin Protein in Drosophila Hemocytes Impairs Immune Responses

  2019cites this paper
• Nutraceuticals and physical activity: their role on oxysterols-mediated neurodegeneration.

  2019cites this paper
• Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

  2019cites this paper
• Reviewing the biochemical implications of normal and mutated huntingtin in Huntington's disease.

  2019cites this paper
• PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

  2019cites this paper
• Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

  2019cites this paper
• Chemical Basis of Reactive Oxygen Species Reactivity and Involvement in Neurodegenerative Diseases

  2019cites this paper
• Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

  2018cites this paper
• Effects of inter-twin vascular anastomoses of monochorionic twins with selective intrauterine growth restriction on the contents of placental mitochondria DNA

  2018cites this paper
• Platelet-derived extracellular vesicles in Huntington’s disease

  2018cites this paper
• Antioxidant and Cell-Signaling Functions of Hydrogen Sulfide in the Central Nervous System

  2018cites this paper
• Huntington’s Disease

  2018cites this paper
• Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders

  2018cites this paper
• Biofluid Biomarkers in Huntington's Disease.

  2018influential citation
• Elucidating regulators and biomarkers of synaptic stability during neurodegeneration

  2018cites this paper
• Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model

  2018cites this paper
• Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients

  2018cites this paper
• Ferroptosis and Its Role in Diverse Brain Diseases

  2018cites this paper
• The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases

  2018cites this paper
• The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions

  2018cites this paper
• Huntington’s disease: novel therapeutic perspectives hanging in the balance

  2018cites this paper
• Developing an antisense oligonucleotide treatment for Spinocerebellar Ataxia Type 3

  2018cites this paper
• Chemical composition, antioxidant potential, macromolecule damage and neuroprotective activity of Convolvulus pluricaulis

  2018cites this paper
• Lipophilic antioxidants in neurodegenerative diseases.

  2018cites this paper
• A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward

  2018influential citation
• 3&bgr;-Hydroxy-urs-12-en-28-oic Acid Modulates Dietary Restriction Mediated Longevity and Ameliorates Toxic Protein Aggregation in C. elegans

  2017cites this paper
• Altered Aconitase 2 Activity in Huntington’s Disease Peripheral Blood Cells and Mouse Model Striatum

  2017cites this paper
• Characterization of conditions and determination of practical tips for mtDNA level estimation in various human cells.

  2017cites this paper
• Neurotoxicity Pathways in Drosophila Models of the Polyglutamine Disorders.

  2017cites this paper
• Mitochondrial dysfunction and metabolic intervention

  2017cites this paper
• Nrf2 and rip140 as new therapeutic targets for x-linked adrenoleukodystrophy (x-ald): control of redox/metabolic homeostasis and inflammation

  2017cites this paper
• Huntington’s Disease: Calcium Dyshomeostasis and Pathology Models

  2017cites this paper
• Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?

  2017cites this paper